Clinical Trial Update: A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated how baricitinib behaves in participants with liver disease and hepatic impairment; results were posted after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency
• Liver Disease

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Liver Diseases, Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2017-04-21